JB Pharma Celebrates 1 Year To Its Identity Launch, Delivers Over 22% Growth For The Fiscal
Nikhil Chopra, CEO, JB Pharma Records revenue growth of 22% to INR 762 crores in Q4 FY23 and grew 30% to INR 3149 crores in FY23 & operating EBITDA increased by 21% to INR 181…





